BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 04, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

liraglutide regulatory update

Novo Nordisk said formal feedback from FDA on an NDA for liraglutide to treat Type II diabetes is expected "within weeks." The...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >